Navigation Links
Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
Date:2/9/2010

Age, gender, genetics affect odds of remaining recurrence-free, research shows

TUESDAY, Feb. 9 (HealthDay News) -- U.S. scientists have discovered there are genetic profiles that play a part in prognosis with non-small cell lung cancers, and those profiles differ depending on the age and gender of the patient.

The researchers analyzed genetic and clinical data from 787 patients who were divided into subgroups based on sex and age (below or above age 70). The findings are published in the Feb. 10 issue of the Journal of the American Medical Association.

In those younger than 70, 25 percent of high-risk patients (those with the shortest recurrence-free survival) showed increased activation of a gene called Src, compared to 6 percent of low-risk patients. In addition, activation of tumor necrosis factor pathways (which are related to death of cells or tissue) was seen in 76 percent of high-risk patients and in 42 percent of low-risk patients.

Among patients aged 70 and older, high-risk patients showed increased activation of the wound healing pathways (40 percent vs. 24 percent) and invasiveness pathways (64 percent vs. 20 percent) compared to low-risk patients, the study authors reported.

The study also found gender differences in lung cancer biology. High-risk female patients had increased activation of the invasiveness and STAT3 gene pathways, while high-risk male patients had increased activation of the STAT3, tumor necrosis factor, wound healing and epidermal growth factor receptor (EGFR) pathways. EGFR is a protein that promotes cell growth and multiplication.

"We believe our findings represent a [new] approach to defining clinically relevant cohorts of non-small cell lung cancer stratified by age and sex that are enriched for specific pathway activity and that would be more apt for therapeutic intervention when planning clinical trials with drugs that target specific pathway-related abnormalities or tumor biology," wrote William Mostertz, of Duke University, and colleagues.

"With genomic [tests] now being increasingly practical and clinically applicable, with turnaround times of five to seven days, we believe our findings . . . represent a step forward in defining pathway-driven cohorts of non-small cell lung cancer that likely explain the age- and sex-specific difference seen in non-small cell lung cancer," the researchers concluded.

More information

The American Cancer Society has more about non-small cell lung cancer.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, Feb. 9, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Scientists Spot Genes Tied to Aging
2. Scientists ID a protein that splices and dices genes
3. Genes May Influence Preterm Births
4. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
5. Genes of pregnant women and their fetuses can increase the risk of preterm labor
6. NIH scientists identify maternal and fetal genes that increase preterm birth risk
7. Very Obese People May Be Missing Genes
8. Scientists map out regulatory regions of genome, hot spots for diabetes genes
9. Mutating Genes May Lead to Premature Births
10. Genes, Diet Offer New Clues to Parkinsons Disease
11. Discovery Links Genes to Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: